CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
- Status
- COMPLETED
- Phase
- PHASE2
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
- Status
- TERMINATED
- Phase
- PHASE3
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
- Status
- UNKNOWN
- Phase
- PHASE4
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Haploidentical Stem Cell Transplantation in Neuroblastoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Hematopoietic Stem Cell Transplant in Devic's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allo-hNHL (FluBuCy)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
- Status
- COMPLETED
- Phase
- PHASE3
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
- Status
- TERMINATED
- Phase
- NA
Zevalin® First Line in Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2